Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
oncolytic virus
|
| gptkbp:clinicalTrialPhase |
Phase 1
NCT04791236 |
| gptkbp:developedBy |
Oncorus, Inc.
|
| gptkbp:engineeredFeatures |
expresses immunomodulatory transgenes
genetically modified for tumor selectivity |
| https://www.w3.org/2000/01/rdf-schema#label |
ONCR-021
|
| gptkbp:mechanismOfAction |
oncolytic HSV-1 virus
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
clinical development
|
| gptkbp:target |
solid tumors
|
| gptkbp:bfsParent |
gptkb:Oncorus
|
| gptkbp:bfsLayer |
8
|